← All organizations
Highest phase reached
Phase 4
First clinical trial
Apr 1, 2007Last known activity
Aug 1, 2024
Timeline
1970s
- Jun 1, 1979
Hamad Medical Corporation— Founded
Drugs by trial phase (77 distinct, 58 trials)
Phase 4 (29 own, 0 via acquisition)
Phase 3 (27 own, 0 via acquisition)
Phase 1 (4 own, 0 via acquisition)
Indications
Studied for
- Acalculous Cholecystitis
- Anaphylaxis
- Anemia
- Arthritis
- Arthritis, Rheumatoid
- Asthma
- beta-Thalassemia
- Brain Diseases
- Brain Injuries
- Brain Injuries, Traumatic
- Brain Ischemia
- Bronchiolitis
- Calculi
- Cholecystitis
- Cholecystitis, Acute
- Choledocholithiasis
- Cicatrix
- Colic
- Communicable Diseases
- Coronavirus Infections
- Critical Illness
- Diabetic Nephropathies
- Emergencies
- Fever
- Fractures, Stress
- Gastroenteritis
- Glomerulonephritis
- Glucose Intolerance
- Hematologic Diseases
- Hyperglycemia
- Hypertension
- Hypertension, Pulmonary
- Hypothermia
- Hypoxia
- Hypoxia-Ischemia, Brain
- Infarction
- Infections
- Infertility
- Infertility, Male
- Ischemia
- Kidney Diseases
- Kidney Failure, Chronic
- Leukemia
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive
- Leukemia, Myeloid
- Leukemia, Myeloid, Chronic-Phase
- Metabolic Diseases
- Myocardial Infarction
- Osteoporosis
- Persistent Fetal Circulation Syndrome
- Pneumonia
- Prediabetic State
- Procedural Pain
- Pyelonephritis
- Renal Colic
- Respiratory Distress Syndrome
- Respiratory Insufficiency
- Seizures
- Severe Acute Respiratory Syndrome
- Shock
- Shock, Septic
- Stress, Psychological
- Stroke
- Thalassemia
- Thrombosis
- Urinary Calculi
- Urinary Tract Infections
- Virus Diseases
- Vitamin D Deficiency
- Vomiting
- Wounds and Injuries
Recent trials (50)
- NCT06548477Sponsor investigatorN/AAug 1, 2024
- NCT06548477Lead sponsorN/AAug 1, 2024
- NCT06548477OfficialN/AAug 1, 2024
- NCT06266767Lead sponsorPhase 4Feb 21, 2024
- NCT06266767OfficialPhase 4Feb 21, 2024
- NCT06077682Reponsible party - principal investigatorPhase 4Sep 1, 2023
- NCT06077682Sponsor investigatorPhase 4Sep 1, 2023
- NCT05579418Lead sponsorPhase 4Nov 1, 2022
- NCT05579418Overall official - principal investigatorPhase 4Nov 1, 2022
- NCT05579418Reponsible party - principal investigatorPhase 4Nov 1, 2022
- NCT05165992Lead sponsorPhase 3Feb 28, 2022
- NCT05061654Overall official - principal investigatorPhase 4Feb 28, 2022
- NCT05165992Overall official - principal investigatorPhase 3Feb 28, 2022
- NCT05061654Lead sponsorPhase 4Feb 28, 2022
- NCT05118737Lead sponsorEarly Phase 1Oct 1, 2021
Details
- Founded
- Doha, QA Jun 1, 1979
- Last known activity
- Aug 1, 2024